Valereum PLC - Holding(s) in Company
Released
Released
Announcement PDF
RNS Number : 7095T
Valereum PLC
07 September 2026
Date: 7 September 2026
FOR IMMEDIATE RELEASE (Aquis Stock Exchange: VLRM)
Valereum Plc
("Valereum", "VLRM" or the "Company")
Holdings in the Company
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GI000A2P2W41
Issuer Name
Valereum PLC
UK or Non-UK Issuer
Non-UK
2. Reason for Notification
An acquisition or disposal of voting rights
3. Details of person subject to the notification obligation
Name
Quorium Global Photonics SPC
City of registered office (if applicable)
Grand Cayman
Country of registered office (if applicable)
Cayman Islands
4. Details of the shareholder
Full name of shareholder(s) if different from the person(s) subject to the notification obligation,
above
City of registered office (if applicable)
Country of registered office (if applicable)
5. Date on which the threshold was crossed or reached
2-Sep-2026
6. Date on which Issuer notified
7-Sep-2026
7. Total positions of person(s) subject to the notification obligation
% of voting rights
attached to shares
(total of 8.A)
% of voting rights
through financial
instruments (total of
8.B 1 + 8.B 2)
Total of both in
% (8.A + 8.B)
Total number of
voting rights held in
issuer
Resulting situation
on the date on which
threshold was
crossed or reached
49.898745 0.000000 49.898745 298111439
Position of previous
notification (if
applicable)
44.841401 0.000000 44.841401 243234439
8. Notified details of the resulting situation on the date on which the threshold was crossed or
reached
8A. Voting rights attached to shares
Class/Type of shares
ISIN code(if possible)
Number of direct voting
rights (DTR5.1)
Number of indirect
voting rights
(DTR5.2.1)
% of direct voting
rights (DTR5.1)
% of indirect voting
rights (DTR5.2.1)
GI000A2P2W41 298111439 0 49.898745 0.000000
Sub Total 8.A 298111439 49.898745%
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial
instrument
Expiration
date
Exercise/conversion
period
Number of voting rights that may be acquired if
the instrument is exercised/converted
% of
voting
rights
Sub Total 8.B1
8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
Type of financial
instrument
Expiration
date
Exercise/conversion
period
Physical or cash
settlement
Number of voting
rights
% of voting
rights
Sub Total 8.B2
9. Information in relation to the person subject to the notification obligation
2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments
are effectively held starting with the ultimate controlling natural person or legal entities (please add
additional rows as necessary)
Ultimate controlling
person
Name of controlled
undertaking
% of voting rights if it
equals or is higher than
the notifiable threshold
% of voting rights through
financial instruments if it
equals or is higher than the
notifiable threshold
Total of both if it equals
or is higher than the
notifiable threshold
Steven Fathers Quorium
Global
49.898745 0.000000 49.898745 %
Photonics
SPC
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
12. Date of Completion
7-Sep-2026
13. Place Of Completion
Aquis Stock Exchange
For further information, please contact:
Valereum Plc
Karl Moss
Tel: +44 7938 767319
Investor Hub
Fortified Securities
Guy Wheatley Tel: +44 203 4117773
Aquis Corporate Adviser
Guild Financial Advisory Limited
Ross Andrews E: ross.andrews@guildfin.co.uk
The Directors of the Company accept responsibility for the contents of this announcement.
Please visit the Company's website at www.vlrm.com
For more information, and the chance to have your questions directly answered by the management
team, please head to our interactive investor hub via: Investor Hub.
IMPORTANT NOTICES
The Company holds cryptocurrencies or crypto assets in its treasury. Whilst the Board of Directors of the
Company considers holding cryptocurrencies to be in the best interests of the Company, the Board
remains aware that the financial regulator in the UK (the Financial Conduct Authority or FCA) considers
investment in cryptocurrencies to be high risk. At the outset, it is important to note that an investment in
the Company is not an investment in cryptocurrencies, either directly or by proxy and shareholders will
have no direct access to the Company's holdings. However, the Board of Directors consider
cryptocurrencies to be an appropriate store of value and potential growth and therefore appropriate for
the Company. Accordingly, the Company is and intends to continue to be materially exposed to
cryptocurrencies.
The Company is neither authorised nor regulated by the FCA, and the purchase of certain
cryptocurrencies are generally unregulated in the UK. As with most other investments, the value of
cryptocurrencies can go down as well as up, and therefore the value of the Company's cryptocurrencies
holdings can fluctuate. The Company may not be able to realise its cryptocurrencies holdings for the
same as it paid to acquire them or even for the value the Company currently ascribes to its
cryptocurrencies positions due to market movements. Neither the Company nor investors in the
Company's shares are protected by the UK's Financial Ombudsman Service or the Financial Services
Compensation Scheme.
Cryptocurrencies may present special risks to the Company's financial position. These risks include (but
are not limited to): (i) the value of cryptocurrencies can be highly volatile, with value dropping as quickly
as it can rise. Investors in cryptocurrencies must be prepared to lose all money invested in
cryptocurrencies; (ii) the cryptocurrencies market is largely unregulated. There is a risk of losing money
due to risks such as cyber-attacks, financial crime and counterparty failure; (iii) the Company may not be
able to sell its cryptocurrencies at will. The ability to sell cryptocurrencies depends on various factors,
including the supply and demand in the market at the relevant time. Operational failings such as
technology outages, cyber-attacks and commingling of funds could cause unwanted delay; and (iv)
crypto assets are characterised in some quarters by high degrees of fraud, money laundering and
financial crime. Prospective investors in the Company are encouraged to do their own research before
investing.
The Company also holds digital tokens as part of its strategy to become the global market leader in the
rapidly developing tokenised digital markets sector. Whilst the Board of Directors of the Company
considers holding tokens to be in the best interests of the Company, it is important to note that an
investment in the Company is not a direct or indirect ownership interest, security, or claim in respect of
any underlying asset or reserve to which a token may relate. The valuation of tokens, particularly those
linked to mining reserves or other physical assets, is inherently uncertain and may depend on
independent third-party verification. Further risks include the liquidity of the tokenised markets, reliance
on the security and continued operation of underlying blockchain or smart contract infrastructure,
counterparty and custody risk in respect of third party platforms, the risk of misrepresentation or fraud
regarding underlying reserves, and evolving regulatory, tax, and accounting treatment. It should not be
assumed that tokens carry rights or protections to traditional securities or regulated investment products
and investors are encouraged to conduct their own due diligence on the Company's exposure to
tokenised assets before making any investment decision.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority
to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information
may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For
further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NEXSSLFFWEMSEDU
Share your feedback
Discover